Goldman Sachs’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23M Buy
1,556,852
+689,210
+79% +$10.2M ﹤0.01% 1677
2025
Q1
$15.5M Sell
867,642
-63,370
-7% -$1.14M ﹤0.01% 1894
2024
Q4
$16.2M Buy
931,012
+228,406
+33% +$3.98M ﹤0.01% 1954
2024
Q3
$9.83M Sell
702,606
-76,043
-10% -$1.06M ﹤0.01% 2278
2024
Q2
$6.4M Buy
778,649
+59,782
+8% +$491K ﹤0.01% 2435
2024
Q1
$5.54M Sell
718,867
-771,881
-52% -$5.95M ﹤0.01% 2489
2023
Q4
$13.4M Sell
1,490,748
-21,339
-1% -$192K ﹤0.01% 1852
2023
Q3
$13.5M Buy
1,512,087
+588,196
+64% +$5.26M ﹤0.01% 1777
2023
Q2
$14.2M Buy
923,891
+132,663
+17% +$2.04M ﹤0.01% 1789
2023
Q1
$17.8M Sell
791,228
-1,848,918
-70% -$41.6M ﹤0.01% 1605
2022
Q4
$55.5M Buy
2,640,146
+86,172
+3% +$1.81M 0.01% 911
2022
Q3
$62.9M Sell
2,553,974
-58,672
-2% -$1.45M 0.02% 837
2022
Q2
$63.3M Buy
2,612,646
+22,539
+0.9% +$546K 0.02% 837
2022
Q1
$66.7M Sell
2,590,107
-3,650
-0.1% -$94.1K 0.01% 891
2021
Q4
$80.5M Buy
2,593,757
+1,500,435
+137% +$46.6M 0.02% 806
2021
Q3
$26.5M Sell
1,093,322
-1,363,958
-56% -$33.1M 0.01% 1516
2021
Q2
$35.9M Buy
2,457,280
+1,629,846
+197% +$23.8M 0.01% 1317
2021
Q1
$20.7M Buy
827,434
+113,468
+16% +$2.83M 0.01% 1660
2020
Q4
$19.5M Buy
713,966
+48,891
+7% +$1.33M 0.01% 1579
2020
Q3
$12.3M Sell
665,075
-187,774
-22% -$3.47M ﹤0.01% 1811
2020
Q2
$17.4M Buy
852,849
+149,359
+21% +$3.05M 0.01% 1567
2020
Q1
$10.3M Buy
703,490
+578,306
+462% +$8.44M ﹤0.01% 1785
2019
Q4
$1.78M Buy
125,184
+65,934
+111% +$936K ﹤0.01% 3003
2019
Q3
$687K Sell
59,250
-341,004
-85% -$3.95M ﹤0.01% 3444
2019
Q2
$8.04M Sell
400,254
-19,990
-5% -$402K ﹤0.01% 2068
2019
Q1
$9.51M Sell
420,244
-151,126
-26% -$3.42M ﹤0.01% 2054
2018
Q4
$12.9M Sell
571,370
-111,046
-16% -$2.51M ﹤0.01% 1795
2018
Q3
$19.6M Buy
682,416
+148,276
+28% +$4.26M 0.01% 1664
2018
Q2
$14.6M Sell
534,140
-566
-0.1% -$15.4K ﹤0.01% 1809
2018
Q1
$12M Sell
534,706
-76,856
-13% -$1.72M ﹤0.01% 1827
2017
Q4
$12.9M Buy
611,562
+17,255
+3% +$364K ﹤0.01% 1777
2017
Q3
$14.8M Buy
594,307
+87,503
+17% +$2.18M ﹤0.01% 1759
2017
Q2
$9.83M Buy
506,804
+182,880
+56% +$3.55M ﹤0.01% 1934
2017
Q1
$5.98M Sell
323,924
-171,663
-35% -$3.17M ﹤0.01% 2105
2016
Q4
$9.38M Sell
495,587
-44,651
-8% -$845K ﹤0.01% 1849
2016
Q3
$12.1M Sell
540,238
-323,762
-37% -$7.25M ﹤0.01% 1750
2016
Q2
$15.4M Buy
864,000
+41,573
+5% +$740K 0.01% 1534
2016
Q1
$11.2M Buy
822,427
+302,245
+58% +$4.13M ﹤0.01% 1661
2015
Q4
$10M Buy
520,182
+17,130
+3% +$330K ﹤0.01% 1680
2015
Q3
$10.2M Buy
503,052
+487,267
+3,087% +$9.87M ﹤0.01% 1630
2015
Q2
$523K Sell
15,785
-471,277
-97% -$15.6M ﹤0.01% 3321
2015
Q1
$11.7M Buy
487,062
+278,263
+133% +$6.67M ﹤0.01% 1583
2014
Q4
$2.56M Buy
208,799
+181,635
+669% +$2.22M ﹤0.01% 2363
2014
Q3
$245K Buy
+27,164
New +$245K ﹤0.01% 3809